|
|
|
|
Дата |
|---|
| 25.06.2026 |
| 24.06.2026 |
| 23.06.2026 |
| 22.06.2026 |
| 21.06.2026 |
| 18.06.2026 |
| 16.06.2026 |
| 15.06.2026 |
| 14.06.2026 |
| 11.06.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
71.02
|
71.27
|
73.10
|
71.44
|
|
|
2 928 015.21
|
159.00
|
|
|
|
73.19
|
71.00
|
73.44
|
71.02
|
|
|
1 969 502.51
|
186.00
|
|
|
|
72.47
|
71.00
|
74.20
|
73.19
|
|
|
4 673 184.89
|
243.00
|
|
|
|
72.96
|
72.05
|
72.99
|
72.47
|
|
|
877 292.77
|
98.00
|
|
|
|
71.36
|
71.13
|
72.99
|
72.96
|
|
|
2 216 945.91
|
177.00
|
|
|
|
71.82
|
71.07
|
72.22
|
71.36
|
|
|
735 040.51
|
79.00
|
|
|
|
70.84
|
70.00
|
72.25
|
71.82
|
|
|
2 849 739.45
|
158.00
|
|
|
|
71.63
|
70.51
|
72.00
|
70.84
|
|
|
1 061 659.98
|
132.00
|
|
|
|
69.17
|
69.40
|
72.90
|
71.63
|
|
|
2 408 887.83
|
203.00
|
|
|
|
70.39
|
68.34
|
71.80
|
69.17
|
|
|
2 664 630.58
|
250.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
08.01.2026
|
11.01.2026 |
1 EGP |
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
